NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients with Type 2 Diabetes: STRONG-DM Study
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Sep 9, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The STRONG-DM Study is a clinical trial aimed at understanding how to better prevent heart failure in patients with type 2 diabetes. The researchers are testing a new approach that combines a special heart failure risk assessment tool with a blood test called NT-proBNP, which helps determine the risk of heart problems. By identifying patients who are at high risk, the study aims to provide targeted prevention strategies and treatments that are based on the latest medical guidelines.
To join this study, participants need to be patients who are seeing a primary care provider for their diabetes. It is important to note that the study is currently recruiting participants of all ages and genders. If you or a family member are eligible, you can expect to be part of a program that actively works to reduce the risk of heart failure through careful monitoring and personalized care. This trial could help improve how healthcare providers manage heart health in people with diabetes, potentially leading to better outcomes for many patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary Care Provider that sees diabetes patients in clinic
- Exclusion Criteria:
- • Provider does not see patients with Diabetes
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported